Dublin, Aug. 26, 2022 (GLOBE NEWSWIRE) — The report “Medical Tourism Market Analysis by Treatment and Region – Global Forecast to 2029” has been added to from ResearchAndMarkets.com offer.
The global medical tourism market size is estimated to be USD 46.96 billion in 2021 and is expected to witness a CAGR of 10.79% during the forecast period.
This is due to hassle-free and affordable international travel, rising healthcare expenditures in developed countries, strict reimbursement policies in local services, and the need for quality services. Factors such as additional advantages in other countries, advanced technology, sophisticated devices, efficient practitioners, low cost and better hospitality coupled with personalized care are also driving the market growth.
However, visa issues, high commissions and scams through middlemen, language barriers, documentation issues and heavy insurance reimbursements are expected to hamper growth.
Per treatment
Based on treatment, the market is segmented into dental, cosmetic, orthopedic, cardiovascular, fertility, bariatric, ophthalmic, and others. In 2021, the cosmetic segment accounted for a large share of revenue due to growing treatment awareness, shift in customer perception for cosmetic surgeries, introduction of advanced technologies and associated rapid procedures to better results. The cardiovascular treatments segment is expected to grow at the highest CAGR over the forecast period owing to the growing prevalence of cardiovascular disorders.
Regional outlook
In 2021, North America was the most revenue-generating region in the global market owing to the presence of well-developed healthcare infrastructure, technological advancements, and increasing disposable income. However, Asia-Pacific is expected to grow at the fastest CAGR over the forecast period. This is due to low medical expenses, better hospitality, increased visa approvals, and the availability of highly qualified, proven doctors.
Thailand, India, China, South Korea, Malaysia, and Singapore are the dominant regions in Asia-Pacific due to the availability of low-cost advanced healthcare services in these regions. Competitor Overview Some of the major companies in the market are TMC Fertility (Malaysia), Sunway Medical Center (India), Mexicali Bariatric Center (Mexico), Hospital San Jose (Mexico), Fortis Healthcare Limited (India), Artemis Hospital (India), Asian Heart Institute (India), Apollo Hospitals Enterprise Ltd. (India), Bangkok Dusit Medical Services (Thailand) and Yanhee International Hospital (Thailand).
Increased investment in healthcare infrastructure, introduction of new healthcare services and packages, availability of comprehensive insurance, and strategic collaborations and acquisitions are some of the key strategies adopted by major players operating in industry. This comprehensive research report focuses on market size and forecast at global, segmental, regional and country level, as well as key market trends and dynamics from 2021 to 2029.
Main topics covered:
1. Research methodology
2. Introduction: Medical Tourism
3. Executive Summary
4. Market dynamics
4.1. Market factors
4.2. Market restriction
4.3. Market opportunities
4.4. Market trends
4.5. Market challenges
5. Analysis of the market environment
5.1. Porter’s 5 forces analysis
5.2. PESTEL analysis
5.3. Value chain analysis
5.4. SWOT analysis
5.5. Reference
6. COVID-19 Impact Analysis: Medical Tourism Market
6.1. COVID-19: Overview
6.2. Impact of COVID-19 on the global market
6.3. Impact of COVID-19 on regional markets
7. Market Analysis by Treatment Type
7.1. Cosmetic treatment
7.1.1. Cosmetic Treatment Market Forecast, 2021-2029 (USD Million)
7.2. dental treatment
7.2.1. Dental Care Market Forecast, 2021-2029 (USD Million)
7.3. orthopedic treatment
7.3.1. Orthopedic Treatment Market Forecast, 2021-2029 (USD Million)
7.4. Neurological treatment
7.4.1. Neurological Treatment Market Forecast, 2021-2029 (USD Million)
7.5. Cancer treatment
7.5.1. Cancer Treatment Market Forecast, 2021-2029 (USD Million)
7.6. Fertility treatment
7.6.1. Fertility Treatment Market Forecast, 2021-2029 (USD Million)
7.7. Cardiovascular treatment
7.7.1. Cardiovascular Treatment Market Forecast, 2021-2029 (USD Million)
7.8. Other treatment
7.8.1. Other Treatments Market Forecast, 2021-2029 (USD Million)
8. Regional Market Analysis
8.1. Regional market trends
8.2. Regional market: comparative analysis
9. North America Medical Tourism Market
10. Europe Medical Tourism Market
11. Asia-Pacific Medical Tourism Market
12. Latin America Medical Tourism Market
13. MEA Medical Tourism Market
14. Competitor Analysis
14.1. Market Share Analysis, 2021-2029
14.2. Competitive mapping
14.3. Key Players Market Analysis
14.4. Main recent developments
15. Business Profiles
15.1. Canopy Growth Corporation (Canada)
15.1.1. Company Overview
15.1.2. Company presentation
15.1.3. finance
15.1.4. Product Benchmarking
15.1.5. RECENT DEVELOPMENTS
15.2. Aurora Cannabis Inc. (Canada)
15.2.1. Company Overview
15.2.2. Company presentation
15.2.3. finance
15.2.4. Product Benchmarking
15.2.5. RECENT DEVELOPMENTS
15.3. MedMen (USA)
15.3.1. Company Overview
15.3.2. Company presentation
15.3.3. finance
15.3.4. Product Benchmarking
15.3.5. RECENT DEVELOPMENTS
15.4. Terra Tech Corp. (United States)
15.4.1. Company Overview
15.4.2. Company presentation
15.4.3. finance
15.4.4. Product Benchmarking
15.4.5. RECENT DEVELOPMENTS
15.5. Aphria Inc. (Canada)
15.5.1. Company Overview
15.5.2. Company presentation
15.5.3. finance
15.5.4. Product Benchmarking
15.5.5. RECENT DEVELOPMENTS
15.6. VIVO Cannabis Inc. (Canada)
15.6.1. Company Overview
15.6.2. Company presentation
15.6.3. finance
15.6.4. Product Benchmarking
15.6.5. RECENT DEVELOPMENTS
15.7. The Cronos Group (Canada)
15.7.1. Company Overview
15.7.2. Company presentation
15.7.3. finance
15.7.4. Product Benchmarking
15.7.5. RECENT DEVELOPMENTS
15.8. The Cronos Group (Canada)
15.8.1. Company Overview
15.8.2. Company presentation
15.8.3. finance
15.8.4. Product Benchmarking
15.8.5. RECENT DEVELOPMENTS
15.9. Medical Marijuana Inc. (USA)
15.9.1. Company Overview
15.9.2. Company presentation
15.9.3. finance
15.9.4. Product Benchmarking
15.9.5. RECENT DEVELOPMENTS
15.10. STENOCARE (Denmark)
15.10.1. Company Overview
15.10.2. Company presentation
15.10.3. finance
15.10.4. Product Benchmarking
15.10.5. RECENT DEVELOPMENTS
15.11. Tikun Olam (Israel)
15.11.1. Company Overview
15.11.2. Company presentation
15.11.3. finance
15.11.4. Product Benchmarking
15.11.5. RECENT DEVELOPMENTS
15.12. Organigram Holdings Inc. (Canada)
15.12.1. Company Overview
15.12.2. Company presentation
15.12.3. finance
15.12.4. Product Benchmarking
15.12.5. RECENT DEVELOPMENTS
15.13. Cresco Labs (USA)
15.13.1. Company Overview
15.13.2. Company presentation
15.13.3. finance
15.13.4. Product Benchmarking
15.13.5. RECENT DEVELOPMENTS
15.14. Indiva (Canada)
15.14.1. Company Overview
15.14.2. Company presentation
15.14.3. finance
15.14.4. Product Benchmarking
15.14.5. RECENT DEVELOPMENTS
15.15. Curaleaf Holding Inc. (USA)
15.15.1. Company Overview
15.15.2. Company presentation
15.15.3. finance
15.15.4. Product Benchmarking
15.15.5. RECENT DEVELOPMENTS
15.16. Other top players
16. Conclusion and Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/8o8h54
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Comments are closed.